IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $142,000 | -25.3% | 2,400 | -40.0% | 0.00% | -33.3% |
| Q1 2020 | $190,000 | -22.1% | 4,000 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $244,000 | +1.7% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $240,000 | -7.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $258,000 | -20.6% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $325,000 | +49.8% | 4,000 | -0.2% | 0.00% | +33.3% |
| Q4 2018 | $217,000 | +4.8% | 4,010 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $207,000 | +24.0% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $167,000 | -5.6% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $177,000 | -12.4% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | -0.5% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $203,000 | -0.5% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $204,000 | +26.7% | 4,010 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $161,000 | +16000.0% | 4,010 | +40000.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -99.0% | 10 | -99.8% | 0.00% | -100.0% |
| Q2 2016 | $98,000 | – | 4,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |